# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

X-linked spinal muscular atrophy

Arthrogryposis Multiplex Congenita Distal X-LinkedXLSMAAMCX1
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 19 results.
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Completed
Last Changed: Jan 27, 2011
First Received: Mar 16, 2006
Disease(s): Kennedy's Disease, Spinal and Bulbar Muscular Atrophy
Intervention(s): Dutasteride, Placebo
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
Status: Recruiting
Last Changed: Aug 13, 2018
First Received: Jun 13, 2018
Disease(s): Spinal and Bulbar Muscular Atrophy
Intervention(s): Leuprorelin Acetate
Locations: Takeda Selected Site, Tokyo, Japan
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
Status: Completed
Last Changed: Apr 10, 2019
First Received: Dec 31, 2013
Disease(s): Spinal and Bulbar Muscular Atrophy
Intervention(s): BVS857, Placebo
Locations: Novartis Investigative Site, Orange, California, United States
National Institutes of Health, Bethesda, Maryland, United States
Novartis Investigative Site, Columbus, Ohio, United States
Novartis Investigative Site, Copenhagen, Denmark
Novartis Investigative Site, Ulm, Germany
... and 2 other locations.
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
Status: Completed
Last Changed: Jun 24, 2005
First Received: Feb 25, 2000
Disease(s): Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis, Spinobulbar Muscular Atrophy
Intervention(s): leuprolide, testosterone
High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
Status: Completed
Last Changed: Feb 05, 2018
First Received: Jun 05, 2014
Disease(s): Spinal and Bulbar Muscular Atrophy, Healthy Subjects
Intervention(s): Supervised high intensity training, Optional training, Control period, Unsupervised High intensity training
Locations: Neuromuscular Research Unit, Copenhagen, Denmark
UK Spinal Muscular Atrophy Patient Registry
Status: Recruiting
Last Changed: Mar 25, 2020
First Received: Mar 03, 2020
Disease(s): Spinal Muscular Atrophy, SMA
Intervention(s): Patient Registry
Locations: John Walton Muscular Dystrophy Research Centre, Newcastle Upon Tyne, United Kingdom
Wearable Technology to Assess Gait Function in SMA and DMD
Status: Recruiting
Last Changed: Dec 11, 2019
First Received: Dec 10, 2019
Disease(s): Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy
Locations: Columbia University Medical Center, New York, New York, United States
Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
Status: Completed
Last Changed: May 21, 2015
First Received: Feb 26, 2009
Disease(s): Spinobulbar Muscular Atrophy, Kennedy's Disease
Intervention(s): Goserelin, Electrophysiologic study, tissue biopsy
Locations: Medical Genetics and Molecular Medicine Unit,, Department of Medicine, Ramathibodi Hospital, Bangkok, Thailand
Early Check: Expanded Screening in Newborns
Status: Enrolling by invitation
Last Changed: Dec 17, 2019
First Received: Aug 31, 2018
Disease(s): Spinal Muscular Atrophy, Fragile X Syndrome, Fragile X - Premutation
Intervention(s): Confirmatory Testing
Locations: RTI International, Research Triangle Park, North Carolina, United States
Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
Status: Not yet recruiting
Last Changed: Aug 19, 2020
First Received: Apr 07, 2020
Disease(s): Duchenne Muscular Dystrophy, Spinal Muscular Atrophy
Intervention(s): Alert "AFNOR 3.6"., Alertes " AFNOR 3.6 " et alertes " Guidelines ".